View Clinical Trial (Medical Research Study)
Novel Intervention for Drug Use and HIV Risk Among Anxiety Sensitive Heroin Users
| City: |
|
Washington |
| State: |
|
District of Columbia |
| Zip Code: |
|
20002 |
| Conditions: |
|
Anxiety |
| Purpose: |
|
Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and
above levels of anxiety sensitivity that will involve the testing of a specialized protocol
for improving treatment retention and outcomes for heroin dependent individuals in a
residential substance use treatment. ASTH-HR will integrate established treatment modules
such as Healthy Relationships, along with interoceptive exposure, affect management, and
psycho-education exercises developed for anxiety prevention and treatment programs with
standard substance use treatment.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- exhibit a score of 21 on a self-report measure of anxiety sensitivity
- be in 28 days of residential substance use treatment.
- meet criteria for current opioid dependence as determined by SCID interview
administered at intake.
Exclusion Criteria:
- evidence of limited mental competency
- the inability to give informed, voluntary, written consent to participate
- current psychosis
- current bipolar disorder.
|
| NCT ID: |
|
NCT01196312 |
| Primary Contact: |
|
Carl W Lejuez, PhD Phone: (301)405-5932 Email: clejuez@psyc.umd.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Washington, District of Columbia 20002 United States
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|